Stock 7702 JMS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials JMS Co.,Ltd.

Equities

7702

JP3386050003

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-05 am EDT 		5-day change 1st Jan Change
533 JPY -0.74% Intraday chart for JMS Co.,Ltd. -1.30% +5.96%
May. 14 JMS Co.,Ltd. Provides Earnings Guidance for the Six Months Ending September 2024 and the Full Year Ending March 31, 2025 CI
May. 14 Jms Co.,Ltd. Announces Dividend for the Year Ended March 31, 2024, Payable on June 26, 2024; Provides Dividend Guidance for the Second Quarter Ending September 2024 and Year Ending March 31, 2025 CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization 1 16,333 21,312 23,883 14,904 12,787 13,098
Enterprise Value (EV) 1 28,027 33,743 36,161 26,806 26,206 29,713
P/E ratio 14.1 x 10.8 x 13.8 x 18 x 45.5 x -364 x
Yield 2.39% 1.95% 1.74% 2.79% 3.25% -
Capitalization / Revenue 0.28 x 0.36 x 0.41 x 0.26 x 0.2 x 0.2 x
EV / Revenue 0.48 x 0.58 x 0.63 x 0.46 x 0.41 x 0.46 x
EV / EBITDA 6.22 x 6.16 x 6.74 x 6.17 x 6.07 x 8.62 x
EV / FCF 14 x -266 x -53.1 x 35.1 x -10.6 x -43.8 x
FCF Yield 7.15% -0.38% -1.88% 2.85% -9.42% -2.28%
Price to Book 0.51 x 0.66 x 0.69 x 0.4 x 0.33 x 0.32 x
Nbr of stocks (in thousands) 24,377 24,385 24,421 24,432 24,449 24,482
Reference price 2 670.0 874.0 978.0 610.0 523.0 535.0
Announcement Date 6/26/19 6/26/20 6/24/21 6/23/22 6/28/23 6/26/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales 1 58,059 58,569 57,578 58,169 63,740 65,292
EBITDA 1 4,508 5,475 5,369 4,341 4,319 3,446
EBIT 1 1,464 2,315 2,127 982 726 -268
Operating Margin 2.52% 3.95% 3.69% 1.69% 1.14% -0.41%
Earnings before Tax (EBT) 1 1,480 2,566 2,222 1,075 620 146
Net income 1 1,160 1,977 1,736 826 281 -36
Net margin 2% 3.38% 3.02% 1.42% 0.44% -0.06%
EPS 2 47.59 81.08 71.12 33.81 11.50 -1.471
Free Cash Flow 1 2,003 -127 -680.6 764.4 -2,468 -678
FCF margin 3.45% -0.22% -1.18% 1.31% -3.87% -1.04%
FCF Conversion (EBITDA) 44.44% - - 17.61% - -
FCF Conversion (Net income) 172.7% - - 92.54% - -
Dividend per Share 2 16.00 17.00 17.00 17.00 17.00 -
Announcement Date 6/26/19 6/26/20 6/24/21 6/23/22 6/28/23 6/26/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 27,900 28,275 15,494 14,281 29,975 16,943 14,600 31,248 16,787
EBITDA - - - - - - - - -
EBIT 1 1,046 614 606 -104 -44 515 -111 -320 397
Operating Margin 3.75% 2.17% 3.91% -0.73% -0.15% 3.04% -0.76% -1.02% 2.36%
Earnings before Tax (EBT) 1 1,359 654 549 -78 104 362 -77 -140 398
Net income 1 1,060 497 386 -36 -68 199 -260 -258 312
Net margin 3.8% 1.76% 2.49% -0.25% -0.23% 1.17% -1.78% -0.83% 1.86%
EPS 2 43.46 20.37 15.80 -1.510 -2.800 8.190 -10.66 -10.58 12.79
Dividend per Share 8.500 8.500 - - 8.500 - - 8.500 -
Announcement Date 11/6/20 11/5/21 2/8/22 8/5/22 11/4/22 2/7/23 8/7/23 11/7/23 2/8/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt 1 11,694 12,431 12,278 11,902 13,419 16,615
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.594 x 2.271 x 2.287 x 2.742 x 3.107 x 4.822 x
Free Cash Flow 1 2,003 -127 -681 764 -2,468 -678
ROE (net income / shareholders' equity) 3.66% 6.17% 5.16% 2.26% 0.69% -0.11%
ROA (Net income/ Total Assets) 1.36% 2.16% 1.96% 0.87% 0.62% -0.21%
Assets 1 85,609 91,473 88,576 94,921 45,330 17,102
Book Value Per Share 2 1,303 1,326 1,427 1,513 1,576 1,657
Cash Flow per Share 2 290.0 236.0 244.0 270.0 259.0 421.0
Capex 1 2,823 3,117 2,988 2,857 3,511 2,553
Capex / Sales 4.86% 5.32% 5.19% 4.91% 5.51% 3.91%
Announcement Date 6/26/19 6/26/20 6/24/21 6/23/22 6/28/23 6/26/24
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
JMS CO.,LTD. Stock JMS Co.,Ltd.
+5.96% 81.21M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.50% 181B
MEDTRONIC PLC Stock Medtronic plc
-5.79% 99.52B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.59% 65.82B
DEXCOM, INC. Stock DexCom, Inc.
-8.38% 45.21B
CENCORA, INC. Stock Cencora, Inc.
+8.42% 43.85B
HOYA CORPORATION Stock Hoya Corporation
+10.10% 42.17B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+10.97% 28.75B
TERUMO CORPORATION Stock Terumo Corporation
+18.89% 25.39B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.39% 23.5B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 7702 Stock
  4. Financials JMS Co.,Ltd.